Single-shot universal influenza vaccine
Single-shot universal influenza vaccine
Docket Number
12A-1120322
IP Status
US provisional application
Abstract
The present invention is a new composition of matter comprising of PLGA polymers, M2e antigens, and cyclic dinucleotides in a unique fashion that gives rise to novel characteristics and improved vaccine performance with commercial value.
Technological Advantages
- Enables broad and durable protection against influenza through single-shot vaccination
- applicable to alternative antigens for immunogenicity enhancement
Applications of Technology
- single-shot universal vaccination
- applicable to other weak immunogens to improve antibody induction
Inventor
Che-Ming Jack Hu
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Single-shot universal influenza vaccine